IR@PKUHSC  > 北京大学第一临床医学院
学科主题临床医学
Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice
Mori, T; Yamasaki, S; Masui, F; Matsuda, M; Sasabe, H; Zhou, YF
关键词MMP inhibitor extracellular matrix adenomyosis mice
刊名EXPERIMENTAL BIOLOGY AND MEDICINE
2001-05-01
226期:5页:429-433
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, Research & Experimental
研究领域[WOS]Research & Experimental Medicine
关键词[WOS]CELLS ; PROLACTIN
英文摘要

The inhibitory effects of a novel, orally active matrix metalloproteinase (MMP) inhibitor, ONO-4817, on the development of uterine adenomyosis induced experimentally by pituitary grafting were examined in mice. Mice were given transplants of isologous anterior pituitary glands (PGs) into the right uterine lumen at 7 weeks of age and were fed chow containing 0.1% to 1.0% ONO-4817 from 8 to 14 weeks of age. Mice treated with 0.3% or 1.0% ONO-4817 showed a significantly lower incidence of the development of adenomyosis than vehicle-treated mice. To evaluate the inhibitory effects of ONO-4817 on the progression of the invasion of the adenomyotic tissues, mice receiving PG grafts at 7 weeks of age were treated with 1.0% ONO-4817 from 13 to 17 weeks of age. The degree of pathological progression of adenomyosis was graded from 1 to 5 in increments of 1. The degree of the progression of the lesion was less in the uteri exposed to ONO-4817(2.71 +/- 0.93) than in the uteri not exposed to the inhibitor (4.33 +/- 0.75), Finally, the invasiveness of endometrial stromal cells obtained from adenomyotic uteri into Matrigel consisting mainly of type IV collagen and laminin was examined using an invasion assay. The assay showed that the treatment with ONO-4817 markedly suppressed the invasion of the stromal cells of the adenomyotic uteri into the gel. These results indicate that ONO-4817 may be an effective inhibitor of the development of adenomyosis.

语种英语
WOS记录号WOS:000168542500006
引用统计
被引频次:24[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/64972
专题北京大学第一临床医学院
作者单位1.Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan
2.Ono Pharmaceut Co, Minase Res Inst, Dept Res & Management, Osaka 6188585, Japan
3.Beijing Univ, Teaching Hosp 1, Dept Obstet & Gynecol, Beijing 100034, Peoples R China
推荐引用方式
GB/T 7714
Mori, T,Yamasaki, S,Masui, F,et al. Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice[J]. EXPERIMENTAL BIOLOGY AND MEDICINE,2001,226(5):429-433.
APA Mori, T,Yamasaki, S,Masui, F,Matsuda, M,Sasabe, H,&Zhou, YF.(2001).Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice.EXPERIMENTAL BIOLOGY AND MEDICINE,226(5),429-433.
MLA Mori, T,et al."Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice".EXPERIMENTAL BIOLOGY AND MEDICINE 226.5(2001):429-433.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Mori, T]的文章
[Yamasaki, S]的文章
[Masui, F]的文章
百度学术
百度学术中相似的文章
[Mori, T]的文章
[Yamasaki, S]的文章
[Masui, F]的文章
必应学术
必应学术中相似的文章
[Mori, T]的文章
[Yamasaki, S]的文章
[Masui, F]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。